VRITIMES Unveils Direct Content Delivery in Email for Streamlined Press Release Access

Manila, 07-Nov-2023 – VRITIMES, a trailblazing media technology company, has launched a new feature that allows journalists to read the full body of press releases directly within their email, bypassing the need to click through to the website.

VRITIMES has once again positioned itself at the forefront of media technology innovation with the introduction of its latest feature that promises to enhance the way press releases are consumed by journalists. Understanding the fast-paced nature of newsrooms, VRITIMES has developed a function that embeds the entire content of a press release within the initial email, eliminating the extra step of visiting a separate link.

“In today’s media landscape, immediacy is key. Journalists are inundated with information, and we want to respect their time while ensuring our clients’ stories are heard,” explains Ferry Bayu, CEO of VRITIMES. “By embedding the full press release in the email, we’re streamlining the process, allowing for immediate access to information and facilitating quicker decision-making.”

This innovative approach not only simplifies the workflow for journalists but also increases the visibility of press releases sent through the VRITIMES platform. The feature is designed to align with the company’s mission to create a more efficient and direct line of communication between newsmakers and the media.

Source link

This content was prepared by our news partner, VRITIMES. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Wellcome launches world's largest global prize for mental health science

The prize, in partnership with Nature, will celebrate breakthroughs in mental health science.…

TECNO Unveils Latest TECNO Slim and AIoT Ecosystem, Expands Laptop Business Reach in Spain and France

BERLIN, Sept. 5, 2025 /PRNewswire/ — TECNO, the AI-driven innovative technology brand,…

SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement with Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player

SK Biopharmaceuticals, Korea Institute of Radiological and Medical Sciences collaborate on discovering…